Sonova shows consistent margin focus, stock attracts long-term investors

Sonova Holding AG emphasizes profitability and disciplined capital allocation, while its shares trade on SIX in Zurich. The Swiss hearing-care group combines manufacturing scale with recurring service revenues, a mix that many long-term investors watch closely.

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-28, 13:15.

Sonova Holding AG (CH0012549785) positions its business around attractive margins and steady cash generation from hearing care products and services. The Swiss group is listed on SIX in Zurich, which gives it a clear anchor in the European health-care universe.

How Sonova earns its returns

Sonova reports in two main segments, hearing instruments and cochlear implants, both of which contribute to a broad base of recurring revenues from fittings, upgrades and aftercare services. The company highlights that its distribution network of branded audiology clinics and third-party partners supports utilization of its own devices.

According to its investor presentations, Sonova targets mid-single to high-single digit organic sales growth over the cycle, with adjusted EBITA margins typically in the mid-20 percent range. That margin ambition reflects a focus on premium products, disciplined pricing and cost efficiency in manufacturing and R&D.

Capital allocation and long-term signals

Sonova states that it aims to balance reinvestment in growth, bolt-on acquisitions and returns to shareholders via dividends and buybacks. Over recent years the group has executed several smaller acquisitions to expand its retail audiology footprint and technology portfolio.

Analyst commentary from Swiss brokers often describes Sonova as a structural growth story in hearing care, supported by demographics and under-penetration of hearing solutions. The stock is part of the Swiss Market Index (SMI), which places it alongside other large Swiss health-care names that international investors follow.

The product behind the stock

Sonova generates a large share of its revenues with Phonak-branded hearing aids, including rechargeable behind-the-ear and in-the-ear devices that are fitted and programmed by audiologists. The group complements these with wireless accessories and custom molds that support speech intelligibility in everyday environments.

Where the stock trades today

Sonova Holding AG shares trade on SIX Swiss Exchange in Zurich; the most recent verified quote was 2026-06-28 in Swiss francs, reflecting the company's status as a large Swiss health-care issuer.

Sonova Holding AG at a glance

• Company: Sonova Holding AG
• ISIN: CH0012549785
• WKN: 125497
• Ticker: SOON
• Trading venue: SIX Swiss Exchange, Zurich
• Price (as of 2026-06-28, 11:00): [latest verified] CHF
• Market cap: [latest verified] CHF (as of 2026-06-28)
• Sector / industry: Health Care - Medical Devices
• Index membership: Swiss Market Index (SMI)
• Next earnings date: not officially scheduled

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.